07:00 , Apr 14, 2008 |  BioCentury  |  Finance

Ebb & Flow

PDL BioPharma (NASDAQ:PDLI) last week said it will spin off its biotech pipeline into a newco. It also solidified plans to return more than $500 million, or $4.25 per share, to shareholders in the form...
07:00 , Jun 28, 2004 |  BC Week In Review  |  Company News

Auxeris management update

Auxeris Therapeutics Inc. , St. Louis, Mo.   Business: Musculoskeletal   Hired: William Boyle as CSO, formerly VP of biology at Protein Pathways Inc.  ...
07:00 , May 10, 2004 |  BC Week In Review  |  Company News

Auxeris management update

Auxeris Therapeutics Inc. , St. Louis, Mo.   Business: Musculoskeletal   Hired: Jonathan McIntyre as chief of development technology and operations, formerly chief scientist at Monsanto Co. 's Protein Technologies group  ...
07:00 , Apr 19, 2004 |  BioCentury  |  Tools & Techniques

Boning up on RANKL

Interim Phase II osteoporosis results for Amgen Inc. 's AMG 162 offers proof of clinical concept for targeting the RANK ligand (RANKL) pathway. However, Auxeris Therapeutics Inc. has opted not to go after osteoporosis with...
08:00 , Jan 19, 2004 |  BC Week In Review  |  Company News

Auxeris, Ceros Pharmaceutical Inc. deal

Auxeris acquired all of the IP assets of musculoskeletal company Ceros in a mostly stock deal. The IP covers the use of beta blockers to prevent and treat osteoporosis. Auxeris hopes to enter the clinic...
08:00 , Jan 14, 2004 |  BC Extra  |  Company News

Auxeris acquires Ceros' assets

Auxeris (St. Louis, Mo.) acquired the technology assets of musculoskeletal company Ceros (Cambridge, U.K.). Terms were not disclosed....
08:00 , Feb 10, 2003 |  BC Week In Review  |  Company News

Auxeris scientific advisory board update

Auxeris Therapeutics Inc. , St. Louis, Mo.   Business: Musculoskeletal   Appointed: Gerard Karsenty, professor of molecular and human genetics at Baylor College of Medicine  ...
08:00 , Feb 10, 2003 |  BC Week In Review  |  Company News

Auxeris management update

Auxeris Therapeutics Inc. , St. Louis, Mo.   Business: Musculoskeletal   Hired: Laurent Fischer as president and CEO, formerly president and CEO of Rxcentric Inc.  ...
08:00 , Feb 6, 2003 |  BC Extra  |  Company News

Auxeris names Fischer CEO

Auxeris Therapeutics (St. Louis, Mo.) hired Laurent Fischer as president and CEO. Prior, Fischer was president and COO of Rxcentric Inc. Auxeris is developing therapeutics for bone-related diseases....